glp-1 agonists vs sglt2 inhibitors The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Next generation dual GLP-1/GIP, GLP-1/glucagon,

Oxidative stress and inflammation: It has been shown to have potent antioxidant and anti-inflammatory effects in some test-tube and animal studies (25,26,27)

L-Carnitine deficiency can lead to nerve problems, heart disease, and loss of muscle mass and function

My preference is to recommend natural brightening agents along with a good sunscreen

You are exposing yourself to potential contaminants, dangerous side effects, and the unquantified risk of accelerating cancer growth

Patients using GLP-1 therapies for weight loss often have different expectations and motivations compared to those using them for diabetes

10.1111/adb.12583 26 HolstJ